{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:27:05Z","timestamp":1793406425517,"version":"4.5.0"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                    is a Gram-negative opportunistic pathogen widely distributed in natural and clinical environments, and has increasingly been recognized as a significant cause of nosocomial infections. Owing to its complex intrinsic resistance mechanisms and the continuous evolution of acquired resistance, the clinical management of\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    infections remains highly challenging. Resistance in\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    is mediated by multiple mechanisms, including chromosomally encoded L1\/L2 \u03b2-lactamases, multidrug efflux pump systems, reduced outer membrane permeability, and biofilm formation, as well as the acquisition of resistance determinants via mobile genetic elements. In addition, virulence-associated traits, including quorum sensing systems, and extracellular enzyme production, contribute to host adaptation and persistent infection. Trimethoprim\u2013sulfamethoxazole (TMP\u2013SMX) remains the first-line therapy. However, increasing resistance has been reported in certain regions. Alternative and combination therapies, including minocycline and fluoroquinolones, are increasingly utilized. Meanwhile, emerging strategies such as efflux pump inhibitors, anti-virulence approaches, and bacteriophage therapy have attracted growing attention. This review provides a comprehensive overview of the resistance mechanisms, virulence-associated phenotypes, and current therapeutic advances of\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    , with particular emphasis on resistance evolution and novel treatment strategies. These insights may advance our understanding of host\u2013pathogen interactions and support the development of targeted therapeutic approaches for improved clinical management.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1865350","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:41:15Z","timestamp":1785130875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Antimicrobial resistance mechanisms, treatment challenges, and emerging strategies in Stenotrophomonas maltophilia infections"],"prefix":"10.3389","volume":"16","author":[{"given":"Siyue","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University","place":["Wuhu, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10096-006-0243-7","article-title":"Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004","volume":"26","author":"Aisenberg","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00232","article-title":"Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation","volume":"4","author":"Al-Anazi","year":"2014","journal-title":"Front. Oncol."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnz069","article-title":"The rpf\/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and \u03b2-lactamase induction","volume":"366","author":"Alcaraz","year":"2019","journal-title":"FEMS Microbiol. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1038\/s41598-024-65509-z","article-title":"Temporal analysis of prevalence and antibiotic-resistance patterns in Stenotrophomonas maltophilia clinical isolates in a 19-year retrospective study","volume":"14","author":"Alfonaisan","year":"2024","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dkp271","article-title":"Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia","volume":"64","author":"Al-Hamad","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/10600280231166413","article-title":"Comparison of doxycycline or minocycline to sulfamethoxazole-trimethoprim for treatment of Stenotrophomonas maltophilia pneumonia","volume":"58","author":"Alhayani","year":"2024","journal-title":"Ann. Pharmacother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs","volume":"12","author":"Allen","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40121-025-01170-x","article-title":"Clinical outcomes of eravacycline in patients treated for Stenotrophomonas maltophilia infections","volume":"14","author":"Al Musawa","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1038\/s41467-019-10271-4","article-title":"Modulation of antibiotic sensitivity and biofilm formation in Pseudomonas aeruginosa by interspecies signal analogues","volume":"10","author":"An","year":"2019","journal-title":"Nat. Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1128\/aac.01275-06","article-title":"Dissemination of sul3-containing elements linked to class 1 integrons with an unusual 3' conserved sequence region among Salmonella isolates","volume":"51","author":"Antunes","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jac\/46.6.879","article-title":"A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia","volume":"46","author":"Avison","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s10096-024-04932-6","article-title":"Understanding the rationale and clinical impact of the revised CLSI 2024 minocycline susceptibility breakpoints against Stenotrophomonas maltophilia","volume":"43","author":"Bakthavatchalam","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1163439","article-title":"Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"10","author":"Banar","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/aac.48.2.666-669.2004","article-title":"Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates","volume":"48","author":"Barbolla","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1322853","article-title":"A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them","volume":"13","author":"Bhaumik","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01603-19","article-title":"Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and\/or trimethoprim-sulfamethoxazole","volume":"58","author":"Biagi","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02453-16","article-title":"Vitamin K(3) induces the expression of the Stenotrophomonas maltophilia SmeVWX multidrug efflux pump","volume":"61","author":"Blanco","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01554-24","article-title":"Evidence of dissemination of a clc-type integrative and conjugative element to Stenotrophomonas maltophilia, mediating acquisition of sul1 and other resistance determinants","volume":"69","author":"Boncompagni","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14060550","article-title":"Mutation of smeRv renders Stenotrophomonas maltophilia resistant to first-line antibiotics trimethoprim\/sulfamethoxazole and levofloxacin","volume":"14","author":"Boonyong","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12941-024-00685-4","article-title":"Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"23","author":"Bostanghadiri","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/cmr.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00030-19","article-title":"Advances in the microbiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01524-19","article-title":"Mutations in ribosomal protein RplA or treatment with ribosomal acting antibiotics activates production of aminoglycoside efflux pump SmeYZ in Stenotrophomonas maltophilia","volume":"64","author":"Calvopi\u00f1a","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104293","article-title":"Identification and qualitative characterization of new therapeutic targets in Stenotrophomonas maltophilia through in silico proteome exploration","volume":"149","author":"Chakrabarty","year":"2020","journal-title":"Microb. Pathog."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231174292","article-title":"Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report","volume":"10","author":"Chambers","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jac\/dkh094","article-title":"Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia","volume":"53","author":"Chang","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1128\/aem.71.3.1387-1393.2005","article-title":"Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5","volume":"71","author":"Chang","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front. Microbiol."},{"key":"B27","volume-title":"Antimicrobial resistance surveillance report of the China Antimicrobial Resistance Surveillance System, 2014\u20132019","year":"2021"},{"key":"B37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3343\/alm.2012.32.1.38","article-title":"Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia","volume":"32","author":"Cho","year":"2012","journal-title":"Ann. Lab. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/00365548.2012.732240","article-title":"Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates","volume":"45","author":"Church","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"B95","volume-title":"Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing","year":"2025"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13050369","article-title":"Stenotrophomonas maltophilia outbreak in an ICU: investigation of possible routes of transmission and implementation of infection control measures","volume":"13","author":"Cristina","year":"2024","journal-title":"Pathogens"},{"key":"B152","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/phage.2023.0034","article-title":"A case of persistent intra-abdominal Stenotrophomonas maltophilia infection despite bacteriophage therapy","volume":"5","author":"Cullen","year":"2024","journal-title":"Phage (New Rochelle)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgar.2023.02.018","article-title":"Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"34","author":"Dadashi","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B127","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3855\/jidc.17290","article-title":"Synergistic combination of aztreonam and ceftazidime\/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis","volume":"17","author":"De Almeida Torres","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-015-0100-6","article-title":"Resistance integrons: class 1, 2 and 3 integrons","volume":"14","author":"Deng","year":"2015","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B77","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1462-5822.2003.00306.x","article-title":"Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces","volume":"5","author":"de Oliveira-Garcia","year":"2003","journal-title":"Cell. Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3201\/eid0809.010535","article-title":"Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia","volume":"8","author":"de Oliveira-Garcia","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1128\/iai.00672-15","article-title":"Type II secretion-dependent degradative and cytotoxic activities mediated by Stenotrophomonas maltophilia serine proteases StmPr1 and StmPr2","volume":"83","author":"DuMont","year":"2015","journal-title":"Infect. Immun."},{"key":"B148","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00284-022-02869-7","article-title":"Stenotrophomonas maltophilia: genotypic characterization of virulence genes and the effect of ascorbic acid on biofilm formation","volume":"79","author":"ElBaradei","year":"2022","journal-title":"Curr. Microbiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18502\/ijm.v16i2.15349","article-title":"Antibacterial and antibiofilm activities of diclofenac against levofloxacin-resistant Stenotrophomonas maltophilia isolates; emphasizing repurposing of diclofenac","volume":"16","author":"El-Soudany","year":"2024","journal-title":"Iran. J. Microbiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21608\/ejbo.2023.235085.2479","article-title":"Evaluation of azithromycin and fenugreek oil as anti-virulence agents against Stenotrophomonas maltophilia multidrug resistant clinical isolates","volume":"64","author":"El-Soudany","year":"2024","journal-title":"Egypt. J. Bot."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1128\/aac.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections","volume":"54","author":"Farrell","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12866-022-02466-5","article-title":"Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections","volume":"22","author":"Fluit","year":"2022","journal-title":"BMC Microbiol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020224","article-title":"Integron functionality and genome innovation: an update on the subtle and smart strategy of integrase and gene cassette expression regulation","volume":"10","author":"Fonseca","year":"2022","journal-title":"Microorganisms"},{"key":"B62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11270-018-3799-9","article-title":"Detection of bla PER on an IncA\/C plasmid in Stenotrophomonas maltophilia isolated from Brazilian soil","volume":"229","author":"Furlan","year":"2018","journal-title":"Water Air Soil pollut."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00926","article-title":"Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence","volume":"6","author":"Garc\u00eda","year":"2015","journal-title":"Front. Microbiol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microbiolres14010001","article-title":"Stenotrophomonas maltophilia and its ability to form biofilms","volume":"14","author":"Garc\u00eda","year":"2022","journal-title":"Microbiol. Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/1462-2920.12408","article-title":"Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia","volume":"16","author":"Garc\u00eda-Le\u00f3n","year":"2014","journal-title":"Environ. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1186\/s12879-024-10348-6","article-title":"Correction: Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter study","volume":"24","author":"Gezer","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14787210.2020.1730178","article-title":"Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge","volume":"18","author":"Gil-Gil","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1128\/mmbr.00056-13","article-title":"Integrons: past, present, and future","volume":"78","author":"Gillings","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B123","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/jac\/dkaf024","article-title":"Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia","volume":"80","author":"Graves","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"B125","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13054-019-2649-5","article-title":"Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study","volume":"23","author":"Guerci","year":"2019","journal-title":"Crit. Care"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12121448","article-title":"Quorum quenching with a diffusible signal factor analog in Stenotrophomonas maltophilia","volume":"12","author":"Guill\u00e9n-Navarro","year":"2023","journal-title":"Pathogens"},{"key":"B100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s44280-025-00092-0","article-title":"Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report","volume":"3","author":"Guo","year":"2025","journal-title":"One Health Adv."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.46234\/ccdcw2023.217","article-title":"Multicenter antimicrobial resistance surveillance of clinical isolates from major hospitals - China, 2022","volume":"5","author":"Guo","year":"2023","journal-title":"China CDC Wkly."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01011-24","article-title":"Stenotrophomonas maltophilia bacteremia in adult patients with hematological diseases: clinical characteristics and risk factors for 28-day mortality","volume":"13","author":"Guo","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2016.21.28.30286","article-title":"Outbreak of pulmonary Pseudomonas aeruginosa and Stenotrophomonas maltophilia infections related to contaminated bronchoscope suction valves, Lyon, France, 2014","volume":"21","author":"Guy","year":"2016","journal-title":"Euro Surveill"},{"key":"B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jhin.2013.09.007","article-title":"Outbreak of Stenotrophomonas maltophilia on an intensive care unit","volume":"85","author":"Guyot","year":"2013","journal-title":"J. Hosp. Infect."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10122506","article-title":"Stenotrophomonas maltophilia epidemiology, resistance characteristics, and clinical outcomes: understanding of the recent three years' trends","volume":"10","author":"Hafiz","year":"2022","journal-title":"Microorganisms"},{"key":"B11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jac\/dku491","article-title":"Characterization of a genomic island in Stenotrophomonas maltophilia that carries a novel floR gene variant","volume":"70","author":"He","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/10600280231201850","article-title":"Trimethoprim\/sulfamethoxazole vs minocycline for the treatment of nonurinary monomicrobial Stenotrophomonas maltophilia infections in hospitalized patients","volume":"58","author":"Hevia","year":"2024","journal-title":"Ann. Pharmacother."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad174","article-title":"Successful treatment of persistent Stenotrophomonas maltophilia bacteremia with cefiderocol in an infant","volume":"10","author":"Hsu","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijantimicag.2010.10.025","article-title":"Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron","volume":"37","author":"Hu","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157693","article-title":"Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China","volume":"11","author":"Hu","year":"2016","journal-title":"PloS One"},{"key":"B120","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1179\/1973947814y.0000000168","article-title":"Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations","volume":"26","author":"Hu","year":"2014","journal-title":"J. Chemother."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01013","article-title":"Genome sequencing and comparative analysis of Stenotrophomonas acidaminiphila reveal evolutionary insights into sulfamethoxazole resistance","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010162","article-title":"Hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in patients with hematologic Malignancies-a systematic review and meta-analysis","volume":"60","author":"Huang","year":"2024","journal-title":"Med. (Kaunas)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/23744235.2024.2324365","article-title":"Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis","volume":"56","author":"Huang","year":"2024","journal-title":"Infect. Dis. (Lond)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111784","article-title":"A linkage between SmeIJK efflux pump, cell envelope integrity, and \u03c3E-mediated envelope stress response in Stenotrophomonas maltophilia","volume":"9","author":"Huang","year":"2014","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1128\/jb.188.8.3116-3120.2006","article-title":"Differential biofilm formation and motility associated with lipopolysaccharide\/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia","volume":"188","author":"Huang","year":"2006","journal-title":"J. Bacteriol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00122","article-title":"Quorum sensing signaling and quenching in the multidrug-resistant pathogen Stenotrophomonas maltophilia","volume":"8","author":"Huedo","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00761","article-title":"Decoding the genetic and functional diversity of the DSF quorum-sensing system in Stenotrophomonas maltophilia","volume":"6","author":"Huedo","year":"2015","journal-title":"Front. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147602","article-title":"Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies","volume":"18","author":"Idrees","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B146","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bioteChadv.2012.10.004","article-title":"Quorum sensing inhibitors: an overview","volume":"31","author":"Kalia","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00401","article-title":"Iron and virulence in Stenotrophomonas maltophilia: all we know so far","volume":"8","author":"Kalidasan","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmi.2023.08.029","article-title":"Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"30","author":"Karakonstantis","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01990-21","article-title":"In vitro susceptibility of gram-negative pathogens to cefiderocol in five consecutive annual multinational SIDERO-WT surveillance studies, 2014 to 2019","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B149","doi-asserted-by":"publisher","first-page":"617","DOI":"10.7150\/ijms.23924","article-title":"Anti-biofilm and anti-virulence efficacy of celastrol against Stenotrophomonas maltophilia","volume":"15","author":"Kim","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1093\/molbev\/msv195","article-title":"Amelioration of the fitness costs of antibiotic resistance due to reduced outer membrane permeability by upregulation of alternative porins","volume":"32","author":"Knopp","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac095","article-title":"Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach","volume":"9","author":"Kullar","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106878","article-title":"In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020","volume":"62","author":"Lee","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-17","article-title":"Genomic sequence of temperate phage Smp131 of Stenotrophomonas maltophilia that has similar prophages in xanthomonads","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Microbiol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02797-22","article-title":"\u03c3(P)-NagA-L1\/L2 regulatory circuit involved in \u0394ompA(299-356)-mediated increase in \u03b2-lactam susceptibility in Stenotrophomonas maltophilia","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1325379","article-title":"Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity","volume":"13","author":"Li","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9061216","article-title":"Interplay between OmpA and RpoN regulates flagellar synthesis in Stenotrophomonas maltophilia","volume":"9","author":"Liao","year":"2021","journal-title":"Microorganisms"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1128\/aac.00372-15","article-title":"The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice","volume":"59","author":"Lin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.resmic.2008.11.001","article-title":"The role of AmpR in regulation of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia","volume":"160","author":"Lin","year":"2009","journal-title":"Res. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1128\/aac.01974-13","article-title":"SmeOP-TolCSm efflux pump contributes to the multidrug resistance of Stenotrophomonas maltophilia","volume":"58","author":"Lin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012902","article-title":"Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae","volume":"21","author":"Mammeri","year":"2025","journal-title":"PloS Pathog."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/v13061057","article-title":"The potential of phage therapy against the emerging opportunistic pathogen Stenotrophomonas maltophilia","volume":"13","author":"McCutcheon","year":"2021","journal-title":"Viruses"},{"key":"B111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jgar.2023.05.013","article-title":"First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen","volume":"34","author":"Medioli","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202062096","article-title":"Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole\/trimethoprim a problem","volume":"62","author":"Mendes","year":"2020","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1385631","article-title":"Stenotrophomonas maltophilia virulence: a current view","volume":"15","author":"Mikhailovich","year":"2024","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac040","article-title":"Clinical challenges treating Stenotrophomonas maltophilia infections: an update","volume":"4","author":"Mojica","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00405-19","article-title":"Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia isolates in the United States","volume":"10","author":"Mojica","year":"2019","journal-title":"mBio"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8030092","article-title":"Characterisation of the major extracellular proteases of Stenotrophomonas maltophilia and their effects on pulmonary antiproteases","volume":"8","author":"Molloy","year":"2019","journal-title":"Pathogens"},{"key":"B158","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14787210.2023.2166933","article-title":"Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on Achromobacter, Burkholderia, and Stenotrophomonas isolates","volume":"21","author":"Montoya-Hinojosa","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01699-19","article-title":"In vitro activity of eravacycline against gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10876-016-1097-5","article-title":"Stenotrophomonas and Microbacterium: mediated biogenesis of copper, silver and iron nanoparticles\u2014Proteomic insights and antibacterial properties versus biofilm formation","volume":"28","author":"Mukherjee","year":"2017","journal-title":"J. Cluster Sci."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01436-20","article-title":"In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia","volume":"65","author":"Nakamura","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01502-21","article-title":"Effectors of the Stenotrophomonas maltophilia type IV secretion system mediate killing of clinical isolates of Pseudomonas aeruginosa","volume":"12","author":"Nas","year":"2021","journal-title":"mBio"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020421","article-title":"Plant secondary metabolites on efflux-mediated antibiotic resistant Stenotrophomonas maltophilia: potential of herbal-derived efflux pump inhibitors","volume":"12","author":"Nguyen","year":"2023","journal-title":"Antibiotics (Basel)."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2023.e01798","article-title":"Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy","volume":"32","author":"Osakwe","year":"2023","journal-title":"IDCases."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059140","article-title":"Antibacterial and cytotoxic efficacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain of Stenotrophomonas maltophilia","volume":"8","author":"Oves","year":"2013","journal-title":"PloS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1128\/aac.01723-15","article-title":"Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia","volume":"59","author":"Pak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00088-17","article-title":"Mobile genetic elements associated with antimicrobial resistance","volume":"31","author":"Partridge","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1183\/09031936.05.00096704","article-title":"Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection","volume":"25","author":"Pathmanathan","year":"2005","journal-title":"Eur. Respir. J."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1242369","article-title":"Emergence of the fourth mobile sulfonamide resistance gene sul4 in clinical Salmonella enterica","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1128\/aac.47.3.1169-1172.2003","article-title":"A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland","volume":"47","author":"Perreten","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B153","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s12864-015-1848-y","article-title":"The isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity","volume":"16","author":"Peters","year":"2015","journal-title":"BMC Genomics"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106314","article-title":"Functional network analysis identifies multiple virulence and antibiotic resistance targets in Stenotrophomonas maltophilia","volume":"183","author":"Pinto","year":"2023","journal-title":"Microb. Pathog."},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01349","article-title":"Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens","volume":"9","author":"Pompilio","year":"2018","journal-title":"Front. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9010049","article-title":"Biofilm formation among Stenotrophomonas maltophilia isolates has clinical relevance: the ANSELM prospective multicenter study","volume":"9","author":"Pompilio","year":"2020","journal-title":"Microorganisms"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1128\/asmcr.00005-25","article-title":"Stenotrophomonas maltophilia infective endocarditis complicated by two embolic strokes: a rare case report and treatment approach","volume":"1","author":"Qadabashi","year":"2025","journal-title":"ASM Case Rep."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00121","article-title":"Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm","volume":"4","author":"Ramirez","year":"2013","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40168-017-0379-y","article-title":"Discovery of the fourth mobile sulfonamide resistance gene","volume":"5","author":"Razavi","year":"2017","journal-title":"Microbiome"},{"key":"B137","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7883\/yoken.JJID.2023.389","article-title":"Biofilm eradication of Stenotrophomonas maltophilia by levofloxacin and trimethoprim-sulfamethoxazole","volume":"77","author":"R\u00edo-Chac\u00f3n","year":"2024","journal-title":"Jpn. J. Infect. Dis."},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1440065","article-title":"Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics","volume":"15","author":"Rodrigues","year":"2024","journal-title":"Front. Microbiol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.4076\/1752-1947-3-7389","article-title":"Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report","volume":"3","author":"Rojas","year":"2009","journal-title":"J. Med. Case Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2958.2008.06132.x","article-title":"Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa","volume":"68","author":"Ryan","year":"2008","journal-title":"Mol. Microbiol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00124-25","article-title":"Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023)","volume":"69","author":"Sader","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01433-20","article-title":"Antimicrobial activity of aztreonam-avibactam and comparator agents when tested against a large collection of contemporary Stenotrophomonas maltophilia isolates from medical centers worldwide","volume":"64","author":"Sader","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.cmi.2025.07.001","article-title":"Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic background","volume":"31","author":"Sakr","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"S\u00e1nchez","year":"2015","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1128\/aac.46.11.3386-3393.2002","article-title":"Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF","volume":"46","author":"S\u00e1nchez","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1128\/aac.00714-15","article-title":"The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia","volume":"59","author":"S\u00e1nchez","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00301-18","article-title":"Overexpression of the efflux pumps SmeVWX and SmeDEF is a major cause of resistance to co-trimoxazole in Stenotrophomonas maltophilia","volume":"62","author":"S\u00e1nchez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B138","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4103\/ijmr.IJMR_9_19","article-title":"Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia from North India: trend over a decade (2007-2016)","volume":"152","author":"Sethi","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02712-21","article-title":"In vitro activity of cefiderocol against U.S. and European gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program","volume":"10","author":"Shortridge","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"20193","DOI":"10.1038\/s41598-025-06177-5","article-title":"Unveiling the structure, function and dynamics of StmPr1 in Stenotrophomonas maltophilia virulence","volume":"15","author":"Sommer","year":"2025","journal-title":"Sci. Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1007\/s11696-025-04046-z","article-title":"Repurposing of FDA-approved drugs as potential inhibitors of L1 \u03b2-lactamase in Stenotrophomonas maltophilia","volume":"79","author":"Sreenithya","year":"2025","journal-title":"Chem. Pap."},{"key":"B86","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1556\/030.2023.02059","article-title":"Genotypic and phenotypic insights into virulence factors of nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria (2011-2022)","volume":"70","author":"Strateva","year":"2023","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"B97","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","article-title":"Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/microbiolres14010001","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s10096-023-04648-z","article-title":"Stenotrophomonas maltophilia in people with Cystic Fibrosis: a systematic review of prevalence, risk factors and management","volume":"42","author":"Terlizzi","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40121-025-01117-2","article-title":"Cefiderocol for the treatment of nosocomial bloodstream infections caused by Stenotrophomonas maltophilia: a case series and literature review","volume":"14","author":"Vena","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0005-2017","article-title":"Antimicrobial resistance in Stenotrophomonas spp","volume":"6","author":"Wang","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40121-024-01099-7","article-title":"Epidemiology and antimicrobial resistance of Stenotrophomonas maltophilia in China, 2014-2021","volume":"14","author":"Wang","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.808391","article-title":"Risk factors for acquired Stenotrophomonas maltophilia pneumonia in intensive care unit: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/srep29701","article-title":"Effects of fluoroquinolones and azithromycin on biofilm formation of Stenotrophomonas maltophilia","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0196-6553(99)70077-5","article-title":"Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia","volume":"27","author":"Weber","year":"1999","journal-title":"Am. J. Infect. Control"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac011","article-title":"Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques","volume":"4","author":"Werth","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1345\/aph.1p217","article-title":"Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin","volume":"44","author":"Wood","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"B114","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.2147\/idr.S425061","article-title":"In vitro antimicrobial activity and dose optimization of eravacycline and other tetracycline derivatives against levofloxacin-non-susceptible and\/or trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia","volume":"16","author":"Wu","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071387","article-title":"Genomic analysis of an I1 plasmid hosting a sul3-class 1 integron and bla(SHV-12) within an unusual Escherichia coli ST297 from urban wildlife","volume":"10","author":"Wyrsch","year":"2022","journal-title":"Microorganisms"},{"key":"B154","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00705-024-06148-7","article-title":"Characterization and genomic analysis of phage vB_SmaP_c9-N, a novel Stenotrophomonas maltophilia podophage with antibiofilm activity","volume":"169","author":"Xi","year":"2024","journal-title":"Arch. Virol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12866-020-02019-8","article-title":"Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study","volume":"20","author":"Xiao","year":"2020","journal-title":"BMC Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"S544","DOI":"10.1093\/cid\/ciz827","article-title":"In vitro activity of cefiderocol against a broad range of clinically important gram-negative bacteria","volume":"69","author":"Yamano","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"29743","DOI":"10.1038\/s41598-025-14811-5","article-title":"Isolation and characterization of novel bacteriophages targeting Stenotrophomonas maltophilia","volume":"15","author":"Yamashita","year":"2025","journal-title":"Sci. Rep."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128300","article-title":"Enhancing biofilm penetration and antibiofilm efficacy with protein nanocarriers against pathogenic biofilms","volume":"256","author":"Yan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1488674","article-title":"Revised taxonomic classification of the Stenotrophomonas genomes, providing new insights into the genus Stenotrophomonas","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Microbiol."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/biology11071044","article-title":"The contribution of efflux systems to levofloxacin resistance in Stenotrophomonas maltophilia clinical strains isolated in Warsaw, Poland","volume":"11","author":"Zaj\u0105c","year":"2022","journal-title":"Biol. (Basel)."},{"key":"B119","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diagmicrobio.2004.09.002","article-title":"Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia","volume":"51","author":"Zelenitsky","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1099\/jmm.0.026377-0","article-title":"Adhesion of Stenotrophomonas maltophilia to mouse tracheal mucus is mediated through flagella","volume":"60","author":"Zgair","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1128\/aac.45.12.3497-3503.2001","article-title":"SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia","volume":"45","author":"Zhang","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/jam.15640","article-title":"Nanocarriers for combating biofilms: advantages and challenges","volume":"133","author":"Zhang","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.2147\/idr.S368338","article-title":"In vitro antibacterial activity and resistance prevention of antimicrobial combinations for dihydropteroate synthase-carrying Stenotrophomonas maltophilia","volume":"15","author":"Zhao","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108409","article-title":"The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia","volume":"9","author":"Zhuo","year":"2014","journal-title":"PloS One"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1865350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:41:17Z","timestamp":1785130877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1865350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":164,"alternative-id":["10.3389\/fcimb.2026.1865350"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1865350","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1865350"}}